Predicting Phenolic Acid Absorption in Caco-2 Cells: A Theoretical Permeability Model and Mechanistic Study

There is a considerable need to rationalize the membrane permeability and mechanism of transport for potential nutraceuticals. The aim of this investigation was to develop a theoretical permeability equation, based on a reported descriptive absorption model, enabling calculation of the transcellular component of absorption across Caco-2 monolayers. Published data for Caco-2 permeability of 30 drugs transported by the transcellular route were correlated with the descriptors 1-octanol/water distribution coefficient (log D, pH 7.4) and size, based on molecular mass. Nonlinear regression analysis was used to derive a set of model parameters a′, β′, and b′ with an integrated molecular mass function. The new theoretical transcellular permeability (TTP) model obtained a good fit of the published data (R2 = 0.93) and predicted reasonably well (R2 = 0.86) the experimental apparent permeability coefficient (Papp) for nine non-training set compounds reportedly transported by the transcellular route. For the first time, the TTP model was used to predict the absorption characteristics of six phenolic acids, and this original investigation was supported by in vitro Caco-2 cell mechanistic studies, which suggested that deviation of the Papp value from the predicted transcellular permeability (Papptrans) may be attributed to involvement of active uptake, efflux transporters, or paracellular flux.

[1]  D. Thakker,et al.  Rhodamine 123 Requires Carrier-Mediated Influx for Its Activity as a P-Glycoprotein Substrate in Caco-2 Cells , 2003, Pharmaceutical Research.

[2]  Y. Kato,et al.  Concentration-Dependent Effect of Naringin on Intestinal Absorption of β1-Adrenoceptor Antagonist Talinolol Mediated by P-Glycoprotein and Organic Anion Transporting Polypeptide (Oatp) , 2009, Pharmaceutical Research.

[3]  A. V. Shileĭko 1 – THEORETICAL PRINCIPLES , 1964 .

[4]  G Folkers,et al.  Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  D. Barron,et al.  Characterization of hydroxycinnamic acid glucuronide and sulfate conjugates by HPLC-DAD-MS(2): enhancing chromatographic quantification and application in Caco-2 cell metabolism. , 2011, Journal of pharmaceutical and biomedical analysis.

[6]  Akira Yamamoto,et al.  Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies. , 2006, International journal of pharmaceutics.

[7]  D. Barron,et al.  Quantitative analysis of plasma caffeic and ferulic acid equivalents by liquid chromatography tandem mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  T. Xiang,et al.  The relationship between permeant size and permeability in lipid bilayer membranes , 1993, The Journal of Membrane Biology.

[9]  H vandeWaterbeemd,et al.  The fundamental variables of the biopharmaceutics classification system (BCS): a commentary. , 1998 .

[10]  Y. Konishi,et al.  Transepithelial transport of chlorogenic acid, caffeic acid, and their colonic metabolites in intestinal caco-2 cell monolayers. , 2004, Journal of agricultural and food chemistry.

[11]  H. van de Waterbeemd The fundamental variables of the biopharmaceutics classification system (BCS): a commentary. , 1998, European Journal of Pharmaceutical Sciences.

[12]  P. Stein,et al.  A Novel Method for the Investigation of Liquid/Liquid Distribution Coefficients and Interface Permeabilities Applied to the Water-Octanol-Drug System , 2011, Pharmaceutical Research.

[13]  H. van de Waterbeemd,et al.  ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.

[14]  Gordon L. Amidon,et al.  Comparison of Human Duodenum and Caco-2 Gene Expression Profiles for 12,000 Gene Sequences Tags and Correlation with Permeability of 26 Drugs , 2002, Pharmaceutical Research.

[15]  S. Akanuma,et al.  Lipophilicity and Transporter Influence on Blood-Retinal Barrier Permeability: A Comparison with Blood-Brain Barrier Permeability , 2010, Pharmaceutical Research.

[16]  Kiyohiko Sugano,et al.  Prediction of oral drug absorption in humans by theoretical passive absorption model. , 2005, International journal of pharmaceutics.

[17]  Z. Wang,et al.  Analysis of chlorogenic acids in beverages prepared from Chinese health foods and investigation, in vitro, of effects on glucose absorption in cultured Caco-2 cells , 2008 .

[18]  C. Bernards,et al.  Ascorbic Acid Inhibits Spinal Meningeal Catechol‐o‐Methyl Transferase in Vitro, Markedly Increasing Epinephrine Bioavailability , 1997, Anesthesiology.

[19]  Ulf Norinder,et al.  Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs , 2009, Pharmaceutical Research.

[20]  M. Roller,et al.  Contribution of chlorogenic acids to the inhibition of human hepatic glucose-6-phosphatase activity in vitro by Svetol, a standardized decaffeinated green coffee extract. , 2010, Journal of agricultural and food chemistry.

[21]  Thomas J. Raub,et al.  In vitro models for the blood-brain barrier. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.

[22]  G L Amidon,et al.  Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. , 2000, Journal of pharmaceutical sciences.

[23]  H. Waterbeemd Improving compound quality through in vitro and in silico physicochemical profiling. , 2009 .

[24]  P. Soares-da-Silva,et al.  P-glycoprotein and multidrug resistance-associated protein (MRP) reverse the intestinal transport of L-DOPA, a LAT2 substrate , 2006 .

[25]  W. Kirch,et al.  Direct demonstration of small intestinal secretion and site‐dependent absorption of the β‐blocker talinolol in humans , 1996, Clinical pharmacology and therapeutics.

[26]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[27]  F. Hu,et al.  Coffee consumption and risk of type 2 diabetes: a systematic review. , 2005, JAMA.

[28]  Li Di,et al.  Coexistence of passive and carrier-mediated processes in drug transport , 2010, Nature Reviews Drug Discovery.

[29]  Barry Press,et al.  Permeability for intestinal absorption: Caco-2 assay and related issues. , 2008, Current drug metabolism.

[30]  H. Corti,et al.  Octanol-water partition coefficient of glucose, sucrose, and trehalose. , 2005, Carbohydrate research.

[31]  P. Artursson,et al.  Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers , 2007, Nature Protocols.

[32]  Bernard Testa,et al.  Lipophilicity and Its Relationship with Passive Drug Permeation , 2011, Pharmaceutical Research.

[33]  G. Williamson,et al.  Transport and Metabolism of Ferulic Acid through the Colonic Epithelium , 2008, Drug Metabolism and Disposition.

[34]  H. Lennernäs,et al.  Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo , 1996 .

[35]  C. Bernards,et al.  Physical and chemical properties of drug molecules governing their diffusion through the spinal meninges. , 1992, Anesthesiology.

[36]  Alex Avdeef,et al.  How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability? , 2010, Journal of medicinal chemistry.

[37]  Kristina Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1 , 2001 .

[38]  K. Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport. , 2001, Advanced drug delivery reviews.

[39]  J. Alsenz,et al.  Development of a 7-Day, 96-Well Caco-2 Permeability Assay with High-Throughput Direct UV Compound Analysis , 2003, Pharmaceutical Research.

[40]  Kristina Luthman,et al.  Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.

[41]  W. Higuchi,et al.  In vitro model for transport of solutes in three-phase system. I. Theoretical principles. , 1972, Journal of pharmaceutical sciences.

[42]  M. Kataoka,et al.  Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[43]  M. Yazdanian,et al.  Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds , 1998, Pharmaceutical Research.

[44]  W I Higuchi,et al.  In vitro model for transport of solutes in three-phase system. II. Experimental considerations. , 1972, Journal of pharmaceutical sciences.